Update on the diagnosis and management of Trigemino-Autonomic Headaches Arne May REVIEW Pages: 1525 - 1532
News on the genetics, epidemiology, medical care and translational research of Schwannomas C.O. HanemannD.G. Evans REVIEW Pages: 1533 - 1541
Axonal protection achieved in a model of multiple sclerosis using lamotrigine David A. BechtoldSandra J. MillerKenneth J. Smith ORIGINAL COMMUNICATION Pages: 1542 - 1551
Reasons to withhold intra-arterial thrombolysis in clinical practice J. IseneggerK. NedeltchevH.P. Mattle ORIGINAL COMMUNICATION Pages: 1552 - 1556
Essential tremor prevalence is low in Arabic villages in Israel Rivka InzelbergAziz MazaribRobert F. Friedland ORIGINAL COMMUNICATION 27 September 2006 Pages: 1557 - 1560
Comparison of CMT1A and CMT2: similarities and differences Henriette M.E. BienfaitCamiel VerhammeMarianne de Visser ORIGINAL COMMUNICATION 28 August 2006 Pages: 1572 - 1580
Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV Zaza KatsaravaÖzgüt YaldizliMatthias Maschke ORIGINAL PAPER 24 October 2006 Pages: 1581 - 1584
Reversible cerebral angiopathy Mathieu ZuberEmmanuel TouzéJean-Louis Mas ORIGINAL COMMUNICATION 24 October 2006 Pages: 1585 - 1588
The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura Shahir MazaheriMehrdad HajilooiAlireza Rafiei ORIGINAL COMMUNICATION 24 October 2006 Pages: 1589 - 1593
Talking the talk on walking the walk A. HollandR.J. O’ConnorJ.C. Hobart ORIGINAL COMMUNICATION 21 August 2006 Pages: 1594 - 1602
The Rivermead Post Concussion Symptoms Questionnaire Seb PotterEleanor LeighSimon Fleminger ORIGINAL COMMUNICATION 24 October 2006 Pages: 1603 - 1614
Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease Sanneke KoekkoekLaura EggermontJintanat Ananworanich ORIGINAL COMMUNICATION 08 November 2006 Pages: 1615 - 1624
Contrast-enhanced Ultrasound in Dermatomyositis- and Polymyositis Marc-André WeberUta JappeStefan Delorme ORIGINAL COMMUNICATION Pages: 1625 - 1632
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson’s disease Astrid ThomasLaura BonanniMarco Onofrj ORIGINAL COMMUNICATION Pages: 1633 - 1639
Malignant posterior cerebral artery infarction Th. PfefferkornA. DeutschlaenderM. Dichgans LETTER TO THE EDITORS Pages: 1640 - 1641
Amyotrophic lateral sclerosis in an urban setting Clare A. JohnstonBiba R. StantonAmmar Al-Chalabi LETTER TO THE EDITORS Pages: 1642 - 1643
Paroxysmal torticollis and blepharospasm following bilateral cerebellar Infarction Killian O’RourkeSean O’RiordanMichael Hutchinson LETTER TO THE EDITORS Pages: 1644 - 1645
Extensive corpus callosum infarction Konstantinos SpengosGeorgios TsivgoulisVassilios Zis LETTER TO THE EDITORS Pages: 1646 - 1648
Association of genetically proven Huntington’s disease and sporadic amyotrophic lateral sclerosis in a 72-year-old woman Sokratis G. PapageorgiouAlexandra AntelliMarios Panas LETTER TO THE EDITORS Pages: 1649 - 1650
Meningomyeloradiculitis as presenting feature of brucellosis Dimitri RenardGuillaume TaiebStephane Lado LETTER TO THE EDITORS 13 October 2006 Pages: 1651 - 1652
Good news about deep brain stimulation for patients with Parkinson’s disease and dystonia Michael Strupp JOURNAL CLUB Pages: 1661 - 1663
